Table 3.
3D-PRE | 3D-POST | RA-PRE | RA-POST | p | |
---|---|---|---|---|---|
|
PTVTarget |
|
|||
V95% [%] |
99.8 ± 0.2 |
99.9 ± 0.1 |
99.7 ± 0.2 |
99.7 ± 0.2 |
- |
|
PTV Non Target |
|
|||
V95% [%] |
93.7 ± 9.2 |
96.6 ± 4.9 |
86.5 ± 13.8 |
94.5 ± 7.5 |
a,b,d,f |
|
Bladder |
|
|||
D2% [Gy] |
48.5 ± 5.1 |
49.0 ± 5.2 |
47.4 ± 3.6 |
46.1 ± 4.2 |
- |
Mean [Gy] |
33.4 ± 8.5 |
30.1 ± 6.5 |
32.1 ± 5.7 |
30.6 ± 3.8 |
c |
D30% [Gy] |
25.9 ± 5.4 |
18.3 ± 5.7 |
18.7 ± 3.3 |
17.6 ± 2.1 |
a,b,c |
V40Gy [%] |
20.7 ± 12.5 |
14.9 ± 9.5 |
11.9 ± 10.1 |
8.1 ± 5.4 |
a,b,c,d,e,f |
|
Right Femur |
|
|||
Mean [Gy] |
32.0 ± 7.5 |
29.9 ± 6.6 |
19.7 ± 4.5 |
18.4 ± 1.9 |
b,c,d,e |
D2% [Gy] |
41.7 ± 5.6 |
42.7 ± 4.7 |
28.2 ± 7.4 |
28.1 ± 3.9 |
b,c,d,e |
|
Left Femur |
|
|||
Mean [Gy] |
31.9 ± 7.0 |
30.2 ± 6.7 |
18.5 ± 4.4 |
20.1 ± 4.7 |
b,c,d,e |
D2% [Gy] | 41.7 ± 5.4 | 42.5 ± 5.3 | 28.7 ± 7.3 | 28.0 ± 6.8 | b,c,d,e |
The p < 0.05 for: a (3D-Pre vs 3D Post); b (3D-Pre vs RA-Pre); c (3D-Pre vs RA-Post); d (3D Post vs Ra-Pre); e (3D-Post vs RA-Post); f (RA-Pre vs RA-Post).